TLIS (TLIS:NASDAQ) rocketted at $12.12, representing a gain of 20%. On Mon, Jul 19, 2021, TLIS:NASDAQ touched a New 2-Week Intraday Low of $9.61. From Tue, Jul 06, 2021, the stock recorded 44.44% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About TLIS (TLIS:NASDAQ)
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care.
Top 10 Gainers:
- NeuroMetrix, Inc. (NURO:NASDAQ), 207.98%
- LSB Industries, Inc. (LXU:NYSE), 44.63%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 40.78%
- Nova LifeStyle, Inc. (NVFY:NASDAQ), 36.89%
- Ideal Power Inc. (IPWR:NASDAQ), 34.06%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- Endo International plc (ENDP:NASDAQ), 24.7%
- AMC Entertainment Holdings, Inc. (AMC:NYSE), 24.47%
- TLIS (TLIS:NASDAQ), 20%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 19.01%